Jackson, MS - New research suggests that mycophenolate mofetil (MMF) can be used in the management of autoimmune inflammatory myopathy. The finding, published in the March 2005 issue of Rheumatology, ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Clinical trials exploring intravenous immunoglobulin and Janus kinase inhibition headline a robust ...
Early-onset IBM challenges age-centric diagnostic criteria, with symptoms appearing in patients younger than 46. Younger IBM patients show a higher rate of mitochondrial DNA mutations, indicating ...
Idiopathic inflammatory myopathies (IIMs) comprise a group of inflammatory disorders in which there is chronic inflammation of skeletal muscle. This is then followed by muscle weakness. One type of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The mean annual direct and indirect costs related to ...
History gathering should solicit the patient’s abilities or limitations with these activities of daily living (ADLs). The patient may have mild arthralgias. Lungs are the most common extra muscular ...
Idiopathic inflammatory myopathies, known collectively as myositis, are chronic diseases that cause disability, mainly from muscle weakness, despite the use of immunosuppressive therapies. An improved ...
Treatment regimens of steroids and disease-modifying antirheumatic drugs were effective in reducing the short-term death rate among patients with acute exacerbation of interstitial lung disease ...
The final diagnosis was autoimmune inflammatory myositis of the necrotizing myopathy subtype. Annabelle was treated with a loading dose of methylprednisolone sodium succinate (1 g intravenously daily ...
Belonging to the same group of autoimmune diseases, both dermatomyositis and polymyositis cause muscle inflammation and weakness. But dermatomyositis also affects your skin and is more likely to ...
Barcelona, Spain, has taken center stage in global rheumatology by hosting the 2025 Annual Meeting of the European Alliance of Associations for Rheumatology (EULAR). “This is the world’s largest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results